Brazilian Critical Minerals Advances Rare Earth Processing at Ema Project
Brazilian Critical Minerals Limited (ASX: BCM) has reported successful bench-scale testwork demonstrating the ability to significantly upgrade and separate rare earth elements from Ema field trial pregnant liquor solution using proprietary technology developed by Rare Earth Technologies Inc (RETi). The trial achieved a 200-times increase in rare earth concentration, lifting total rare earth oxides excluding cerium from 930 parts per million to 186,000 parts per million, while maintaining near-complete recovery.
Importantly, the process enabled the clean separation of individual rare earth oxides, each reaching a minimum purity of 99.9% within a short processing cycle. The testwork also showed strong rejection of common impurities and low chemical and energy intensity, reinforcing the environmental credentials of the Ema in-situ recovery project. RETi’s technology, already operating at commercial scale in Europe, provides BCM with a technically robust pathway to maximise recoverable value. Further testing and independent validation are planned during 2026 to assess scalability and commercial application.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and Terms & Conditions
Brazilian Critical Minerals Advances Rare Earth Processing at Ema Project
Brazilian Critical Minerals Limited (ASX: BCM) has reported successful bench-scale testwork demonstrating the ability to significantly upgrade and separate rare earth elements from Ema field trial pregnant liquor solution using proprietary technology developed by Rare Earth Technologies Inc (RETi). The trial achieved a 200-times increase in rare earth concentration, lifting total rare earth oxides excluding cerium from 930 parts per million to 186,000 parts per million, while maintaining near-complete recovery.
Importantly, the process enabled the clean separation of individual rare earth oxides, each reaching a minimum purity of 99.9% within a short processing cycle. The testwork also showed strong rejection of common impurities and low chemical and energy intensity, reinforcing the environmental credentials of the Ema in-situ recovery project. RETi’s technology, already operating at commercial scale in Europe, provides BCM with a technically robust pathway to maximise recoverable value. Further testing and independent validation are planned during 2026 to assess scalability and commercial application.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au